The publication of modern slavery statements (statements) on this Register does not indicate compliance with the requirements of the Modern Slavery Act 2018 (the Act). Pursuant to section 19(2) of the Act, the Attorney-General’s Department publishes all statements properly submitted to this Register, including compliant and non-compliant statements, in order to maximise transparency and ensure entities are publicly accountable for their actions to address modern slavery risks. Statements that fail to meet the requirements for approval and signature set out in sections 13(2) or 14(2) of the Act will not be registered.

Number
2023-937
Type
Joint
Title
Labcorp's Combatting Modern Slavery and Anti-Human Trafficking Statement
Period
01 January 2022 to 31 December 2022
Annual revenue
1BN+
Industry sectors
Healthcare and pharmaceuticals
Countries
United States of America
Key brands and business names
Labcorp Drug Development; Laboratory Corporation of America Holdings
Reporting Obligations
California Transparency in Supply Chains Act 2010
United Kingdom Modern Slavery Act 2015
Date submitted
24/06/2023
Date published
05/07/2023